Sabby Capital Reveals New 7.3% Stake In RiceBran Technologies (RIBT)

RiceBran Technologies (NASDAQ:RIBT) has caught the attention of Hal Mintz, who has initiated a new position. In a recent filing with the Securities and Exchange Commission, Mintz’s fund, Sabby Capital, has reported ownership of 575,000 shares, which account for 7.31% of the total number of shares outstanding.

RiceBran Technologies (NASDAQ:RIBT)

No other hedge funds that we track hold RiceBran Technologies (NASDAQ:RIBT) in their portfolio. The company completed a public offering on June 26.  A total of 1,417,500 shares of common stock were offered at a price of $5.29 apiece, with estimated gross proceeds of $7.5 million. The underwriters were awarded options for another 708,750 shares as over-allotments. The company plans to use the proceeds to pay off some of the debt and for working capital needs for its operation in the United States and Brazil.

RiceBran Technologies (NASDAQ:RIBT), formerly known as NutraCea, is a nutrition company, marketing products derived from rice bran. The company has a market cap of $16 million and does not pay a dividend. So far this year, the stock has been oscillating around the $5 level and is currently traded at $5.25 per share. For the three months ending March 31, 2014, RiceBran Technologies posted $7.68 million in revenues and a loss per share of $0.62.

In a recent move, Mintz has initiated a significant new position in Brainstorm Cell Therapeutics Inc (OTCBB:BCLI). Sabby Capital has reported ownership of 22 million shares or 9.79% of the company’s common stock. Another new addition to Sabby’s equity portfolio is Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV): 9.11 million shares. Mintz is also optimistic about the prospects of Bio-Path Holdings Inc (NASDAQ:BPTH), having increased his fund’s stake to 4.45 million shares, which gives him control over 4.9% of the company’s common stock. The fund’s top position continues to be Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), despite the fact that Mintz has reduced it by 21% to approximately 364,750 shares during the first quarter of 2014.

Disclosure: none.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!